Keywords: Tumors (Pre-Treatment), Cancer, IDH-Mutation, 1p/19q Codeletion
Motivation: There is a critical need for improved diagnostic precision in distinguishing between IDH-mutant, 1p/19q non-codeleted astrocytomas and 1p/19q co-deleted oligodendrogliomas. While the T2/FLAIR-mismatch sign is specific for IDH-mutant astrocytomas, its limited sensitivity calls for enhanced diagnostic methods in glioma cohorts.
Goal(s): To evaluate the role of T2/FLAIR-mismatch in combination with qualitative VASARI features to classify IDH-mutant glioma.
Approach: We analyzed VASARI features and the presence of T2/FLAIR-mismatch in 179 IDH-mutant gliomas and determined the predictive accuracy of these features.
Results: Findings indicate the limitations of the T2/FLAIR-mismatch sign for accurate preoperative diagnosis, emphasizing the need for refined noninvasive methods to enhance diagnostic accuracy.
Impact: This research underscores the critical need for improved diagnostic tools in distinguishing glioma subtypes, as the T2/FLAIR-mismatch sign exhibits limitations, risking misclassification. Addressing these challenges is essential for accurate patient management and treatment planning in the context of IDH-mutant gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords